Currently, it is believed that the pathogenesis of PME caused by the SCARB2 gene mutation is mainly related to the reduced expression of SCARB2 protein, the abnormal sub-location and the effect of SCARB2 binding to β-GCase. The gene discussed is SCARB2; the disease is progressive myoclonus epilepsy.